Julie Krop - Jun 15, 2021 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori J. Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 06:50 PM
Next filing
Jun 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Stock Option (Right to Purchase) Award $0 +20K $0.00 20K Jun 15, 2021 Common Stock 20K $4.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.